Role of the subgroups of T, B, natural killer lymphocyte and serum levels of interleukin-15, interleukin-21 and immunoglobulin e in the pathogenesis of urticaria

Journal of Dermatology

Volumn 37, Issue 5, 2010, Pages 441-447

  Huilan, Zhu ^a   Runxiang, Li ^a   Bihua, Liang ^a   Qing, Guo ^b  

^a GUANGZHOU INSTITUTE OF DERMATOLOGY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Interleukin 15; Interleukin 21; Lymphocyte subgroups; Pathogenesis; Urticaria

Indexed keywords

CD3 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 15; INTERLEUKIN 21; INTERLEUKIN DERIVATIVE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CELL FUNCTION; CELLULAR IMMUNITY; CHRONIC URTICARIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE DYSREGULATION; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; T LYMPHOCYTE; URTICARIA; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; IMMUNOLOGY; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-15; INTERLEUKINS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; URTICARIA; YOUNG ADULT;

EID: 77951788944     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00805.x     Document Type: Article

References (41)

1. Pasaoglu G, Bavbek S, Tugcu H, Abadoglu O, Misirligil Z. Psychological status of patients with chronic urticaria. J Dermatol 2006 33 : 765 771.
2. Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007 34 : 294 301.
3. Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF. Pathophysiology of urticaria. Clin Rev Allergy Immunol 2006 30 : 3 11.
4. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004 114 : 465 475.
5. Serhat IH, Ozturk S, Akcali C, Kirtak N, Tarakcioglu M. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. J Dermatol 2008 35 : 276 282.
6. Zuberbier T, Bindslev-jensen C, Canonica W et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006 61 : 316 320.
7. Oswalt ML, Ly TH, Marshall GD. Assessing clinical value of elevated IgE receptor antibody titers (aFη [var epsilon]RI) in patients with chronic urticaria. J Allergy Clin Immunol 2008 121 : 101.
8. Hidvegi B, Nagy E, Szabo T et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol 2003 132 : 177 182.
9. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007 13 : 139 145.
10. Incorvaia C, Frati F, Verna N, D'Alò S, Motolese A, Pucci S. Allergy and the skin. Clin Exp Immunol 2008 153 : 27 29.
11. Coffman RL. Origins of the Th1-Th2 model: a personal perspective. Nat Immunol 2006 7 : 539 541.
12. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006 24 : 677 688.
13. Irinyi B, Aleksza M, Antal-szalmas P, Sipka S, Hunyadi J, Szegedi A. Cytokine production of CD4+ and CD8+ peripheral T lymphocytes in patients with chronic idiopathic urticaria. Acta Derm Venereol 2002 82 : 249 253.
14. Ferrer M, Kaplan AP. Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr) 2007 35 : 57 61.
15. Aoi N, Masuda T, Murakami D et al. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells. J Allergy Clin Immunol 2006 117 : 1359 1366.
16. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001 97 : 14.
17. Ishimitsu R, Nishimura H, Yajima T, Watase T, Kawauchi H, Yoshikai Y. Overexpression of IL-15 in vivo enhances Tc1 response, which inhibits allergic inflammation in a murine model of asthma. J Immunol 2001 166 : 1991 2001.
18. Bamford RN, Grant AJ, Burton JD et al. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994 91 : 4940 4944.
19. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996 4 : 329 336.
20. Carson WE, Fehniger TA, Haldar S et al. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997 99 : 937 943.
21. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 1996 15 : 4928 4939. (Pubitemid 26315803)
22. Bierbaum S, Nickel R, Zitnik S et al. Confirmation of association of IL-15 with pediatric asthma and comparison of different controls. Allergy 2006 61 : 576 580.
23. Ong PY, Hamid QA, Travers JB et al. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 2002 168 : 505 510.
24. Mori A, Suko M, Kaminuma O et al. IL-15 promotes cytokine production of human T helper cells. J Immunol 1996 156 : 2400 2405.
25. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995 154 : 483 490.
26. Masuda A, Matsuguchi T, Yamaki K, Hayakawa T, Yoshikai Y. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J Biol Chem 2001 276 : 26107 26113.
27. Hoontrakoon RH, Chu W, Gardai SJ et al. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am J Respir Cell Mol Biol 2002 26 : 404 412.
28. Fina D, Fantini MC, Pallone F, Monteleone G. Role of interleukin-21 in inflammation and allergy. Inflamm Allergy Drug Targets 2007 6 : 63 68.
29. Wei L, Laurence A, Elias KM, O'Shea JJ. IL-21 is produced by TH17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007 282 : 34605 34610.
30. Shang XZ, Ma KY, Radewonuk J et al. IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response. Cell Immunol 2006 241 : 66 74.
31. Szegedi A, Irinyi B, Gal M et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol 2006 155 : 67 75.
32. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza BA, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999 140 : 446 452.
33. Bratke K, Krieghoff L, Kuepper M, Luttmann W, Virchow JC. CD8+ T cell activation and differentiation in allergic asthma and the impact of cytomegalovirus serological status. Clin Exp Immunol 2007 149 : 311 316.
34. Toubi E, Adir-shani A, Kessel A, Shmuel Z, Sabo E, Hacham H. Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol 2000 20 : 371 378.
35. Garmendia JV, Zabaleta M, Aldrey O et al. Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients. Invest Clin 2006 47 : 361 369.
36. Jianli C. The effect of acupuncture on serum IgE level in patients with chronic urticaria. J Tradit Chin Med 2006 26 : 189 190.
37. Brandt K, Singh PB, Bulfone-paus S, Ruckert R. Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev 2007 18 : 223 232.
38. Liu R, Van Kaer L, La Cava A. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J Immunol 2006 176 : 5247 5254.
39. Chomiciene A, Dubuske LM, Blaziene A. Association of chronic idiopahic urticaria with autoimmunity and IgE levels. J Allergy Clin Immunol 2007 119 : 200 456.
40. Arkwright PD. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol 2009 123 : 510 511.
41. Suto A, Nakajima H, Hirose K et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C (epsilon) transcription of IL-4-stimulated B cells. Blood 2002 100 : 4565 4573.